Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
KDR C482R
i
Other names:
KDR, CD309, FLK1, VEGFR, VEGFR2, Kinase insert domain receptor (a type III receptor tyrosine kinase)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3791
Related biomarkers:
Expression
Mutation
CNA
Others
‹
KDR Q472H (1)
KDR Q472H + KIT M541L (1)
KDR R961W (1)
KDR V297I (1)
KDR V297L (1)
KDR mutation (1)
KDR rs1870377 (1)
KDR rs2071559 (1)
KDR rs2305945 (1)
KDR Q472H (1)
KDR Q472H + KIT M541L (1)
KDR R961W (1)
KDR V297I (1)
KDR V297L (1)
KDR mutation (1)
KDR rs1870377 (1)
KDR rs2071559 (1)
KDR rs2305945 (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
KDR C482R
Clear Cell Renal Cell Carcinoma
KDR C482R
Clear Cell Renal Cell Carcinoma
crizotinib + pazopanib
Sensitive: C3 – Early Trials
crizotinib + pazopanib
Sensitive
:
C3
crizotinib + pazopanib
Sensitive: C3 – Early Trials
crizotinib + pazopanib
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login